glp 1 for liver Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Semaglutide improves metabolic liver disease
Description
For patients with type 2 diabetes and ASCVD, starting a GLP-1 RA carries a Class 1, Level of Evidence A recommendation in the most recent ESC and ACC guidelines
Endocrine disorders such as hyperthyroidism, pheochromocytoma, and carcinoid syndrome can cause excessive sweating
Compounded GLP-1 medications are not FDA-approved
Pro tip: This is why tirzepatide uses a gradual dose escalation schedule
